NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-009-1999-0-PCT-02 AN ATP-BINDING CASETTE PROTEIN RESPONSIBLE FOR CYTOTOXIN RESISTANCE PCT PCT PCT/US1999/028107 Expired
NIAID E-282-1998-0-EP-04 Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases EP National Stage 99965880.0 Abandoned
NIAID E-282-1998-0-GB-11 Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases GB EP 99965880.0 Abandoned
NIAID E-282-1998-0-DE-09 Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases DE EP 99965880.0 Abandoned
NIAID E-282-1998-0-FR-10 Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases FR EP 99965880.0 Abandoned
NIAID E-282-1998-0-AU-03 Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases AU National Stage 21558/00 Abandoned
NCI E-149-1996-0-US-03 NOVEL GENES OF KAPOSI'S SARCOMA ASSOCIATED HERPES VIRUS US National Stage 09/230,637 6264958 Expired PDF
NIAID E-282-1998-0-PCT-02 Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases PCT PCT PCT/US1999/027817 Expired
NIAID E-282-1998-0-JP-05 Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases JP National Stage 2000-583564 Abandoned
NIAID E-282-1998-0-CA-06 Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases CA National Stage 2352963 Abandoned
NCI E-019-2000-1-US-01 INHIBITION OF ABC TRANSPORTERS BY TRANSMENBRANE DOMAIN ANALOGS US 60/166,767 Abandoned
NIDDK E-047-1992-5-US-02 DNA ENCODING A CHOLECYSTOKININ RECEPTOR US DIV 09/443,745 6706493 Abandoned PDF
NIAID E-142-1996-0-US-04 Production Of Attenuated Respiratory Syncytial Virus Vaccines From Cloned Nucleotide Sequences US DIV 09/444,221 Abandoned
NIAID E-142-1996-0-US-03 Production of Attenuated Respiratory Synctial Virus Vaccines From Cloned Nucleotide Sequences US DIV 09/444,067 Abandoned
NCI E-138-1998-0-US-04 METHODS AND COMPOSITIONS FOR DRM, A NUCLEAR PROTEIN WITH CELL CYCLE REGULATING ACTIVITY US CON 09/444,066 Abandoned
NINDS E-292-1999-0-PCT-02 Low Oxygen Culturing of Central Nervous System Progenitor Cells PCT PCT PCT/US1999/027613 Expired
NINDS E-292-1999-0-JP-04 LOW OXYGEN CULTURING OF CENTRAL NERVOUS SYSTEM PROGENITOR CELLS JP National Stage 2000-582534 Expired
NINDS E-292-1999-0-EP-03 LOW OXYGEN CULTURING OF CENTRAL NERVOUS SYSTEM PROGENITOR CELLS EP National Stage 99965857.8 Abandoned
NCI E-019-2000-0-US-01 INHIBITION OF ABC TRANSPORTERS BY TRANSMENBRANE DOMAIN ANALOGS US 60/166,382 Abandoned
NCI E-223-1998-0-PCT-02 P53 and VEGF Regulate Tumor Growth of NOS2 Expressing Cancer Cells PCT PCT PCT/US1999/027410 Expired
NCI E-006-1999-0-PCT-02 Identification of Glycosphingolipids that promote HIV-1 entry into Cells PCT PCT PCT/US1999/027341 Abandoned
NHGRI E-005-1997-0-JP-05 METHOD FOR SIMULTANEOUS DETECTION OF MULTIPLE FLUOROPHORES FOR IN SITU HYBRIDIZATION AND MULTICOLOR CHROMOSOME PAINTING AND BANDING JP National Stage 2000-584297 Expired
NHLBI E-234-1999-1-US-01 Fast Displacement Encoding With Stimulated Magnetic Resonance Echoes By Sampling Both Components Of A Stimulated Echo US 60/165,564 Abandoned
NCI E-256-1998-0-CA-31 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof CA DIV 2678259 Expired
NCI E-256-1998-0-CA-06 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof CA National Stage 2354024 Expired
NCI E-256-1998-0-JP-05 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof JP National Stage 2000-586927 Expired
NCI E-256-1998-0-LU-22 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof LU EP 99958951.8 Expired
NCI E-256-1998-0-BE-14 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof BE EP 99958951.8 Expired
NCI E-256-1998-0-AT-13 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof AT EP 99958951.8 Expired
NCI E-256-1998-0-PT-25 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof PT EP 99958951.8 Expired
NCI E-256-1998-0-ES-26 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof ES EP 99958951.8 Expired
NCI E-256-1998-0-MC-23 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof MC EP 99958951.8 Expired
NCI E-256-1998-0-NL-24 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof NL EP 99958951.8 Expired
NCI E-256-1998-0-FI-17 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof FI EP 99958951.8 Expired
NCI E-256-1998-0-DE-18 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof DE EP 99958951.8 Expired
NCI E-256-1998-0-FR-12 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof FR EP 99958951.8 Expired
NCI E-256-1998-0-CY-15 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof CY EP 99958951.8 Expired
NCI E-256-1998-0-DK-16 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof DK EP 99958951.8 Expired
NCI E-256-1998-0-IE-20 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof IE EP 99958951.8 Expired
NCI E-256-1998-0-IT-21 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof IT EP 99958951.8 Expired
NCI E-256-1998-0-GR-19 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof GR EP 3062570 Expired
NCI E-256-1998-0-CH-28 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof CH EP 99958951.8 Expired
NCI E-256-1998-0-GB-29 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof GB EP 99958951.8 Expired
NCI E-256-1998-0-SE-27 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof SE EP 99958951.8 Expired
NCI E-256-1998-0-EP-04 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof EP National Stage 99958951.8 Expired
NCI E-256-1998-0-AU-03 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof AU National Stage 16218/00 Expired
NCI E-256-1998-0-PCT-02 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof PCT PCT PCT/US1999/026866 Expired
NCI E-256-1998-0-EP-11 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof EP DIV 07107699.6 Abandoned
NIAID E-263-1999-0-US-01 The Use Of Recombinant cholera-Toxin B For The Treatment Of Inflam- matory Bowel Disease US 60/165,111 Abandoned
NCI E-017-2000-0-US-01 COMPOSITIONS AND METHODS FOR THE DIMINUTION OR ELIMINATION OF VARIOUS CANCERS US 60/165,224 Abandoned